JPS61186378A - オキソ化合物の窒素誘導体，その製法及びそれを含む医薬製剤 - Google Patents

オキソ化合物の窒素誘導体，その製法及びそれを含む医薬製剤

Info

Publication number
JPS61186378A
JPS61186378A JP60263978A JP26397885A JPS61186378A JP S61186378 A JPS61186378 A JP S61186378A JP 60263978 A JP60263978 A JP 60263978A JP 26397885 A JP26397885 A JP 26397885A JP S61186378 A JPS61186378 A JP S61186378A
Authority
JP
Japan
Prior art keywords
group
lower alkyl
alkyl group
groups
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60263978A
Other languages
English (en)
Japanese (ja)
Inventor
カール　シヤフナー
ペーター　トラクスラー
マルクス　ズインメルマン
バルター　ベルリ
カール　ハインツ　シユミトルピン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS61186378A publication Critical patent/JPS61186378A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP60263978A 1984-11-26 1985-11-26 オキソ化合物の窒素誘導体，その製法及びそれを含む医薬製剤 Pending JPS61186378A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH562984 1984-11-26
CH5629/84-7 1984-11-26

Publications (1)

Publication Number Publication Date
JPS61186378A true JPS61186378A (ja) 1986-08-20

Family

ID=4296800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60263978A Pending JPS61186378A (ja) 1984-11-26 1985-11-26 オキソ化合物の窒素誘導体，その製法及びそれを含む医薬製剤

Country Status (20)

Country Link
EP (1) EP0183649A1 (enExample)
JP (1) JPS61186378A (enExample)
KR (1) KR860004047A (enExample)
AU (1) AU5034885A (enExample)
DD (1) DD239203A5 (enExample)
DK (1) DK544485A (enExample)
FI (1) FI854632A7 (enExample)
GR (1) GR852843B (enExample)
IL (1) IL77139A0 (enExample)
MA (1) MA20578A1 (enExample)
MC (1) MC1710A1 (enExample)
MT (1) MTP974B (enExample)
MW (1) MW3985A1 (enExample)
NO (1) NO854712L (enExample)
OA (1) OA08542A (enExample)
PL (1) PL256440A1 (enExample)
PT (1) PT81554B (enExample)
ZA (1) ZA858992B (enExample)
ZM (1) ZM8785A1 (enExample)
ZW (1) ZW20985A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962944B2 (en) * 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
CN116730969B (zh) * 2023-06-26 2024-04-19 中国药科大学 一种β-拉帕醌-氨基酸缀合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3154565A (en) * 1962-03-22 1964-10-27 Merck & Co Inc Chromenyl compounds and method of preparing
AT334896B (de) * 1973-09-28 1977-02-10 Erba Carlo Spa Verfahren zum herstellen von neuen 1-oxo-1h-naphtho (2,1-b)pyranderivaten
DE2654796A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Polyoxygenierte labdan-derivate

Also Published As

Publication number Publication date
DK544485D0 (da) 1985-11-25
ZA858992B (en) 1986-07-30
EP0183649A1 (de) 1986-06-04
DK544485A (da) 1986-05-27
PT81554B (en) 1987-09-21
FI854632A7 (fi) 1986-05-27
DD239203A5 (de) 1986-09-17
NO854712L (no) 1985-05-27
MC1710A1 (fr) 1986-09-22
KR860004047A (ko) 1986-06-16
PT81554A (en) 1985-12-01
MTP974B (en) 1990-03-30
MW3985A1 (en) 1986-12-10
ZM8785A1 (en) 1986-06-27
OA08542A (fr) 1988-09-30
ZW20985A1 (en) 1986-06-25
AU5034885A (en) 1986-06-05
PL256440A1 (en) 1986-10-07
IL77139A0 (en) 1986-04-29
MA20578A1 (fr) 1986-07-01
GR852843B (enExample) 1986-03-21
FI854632A0 (fi) 1985-11-22

Similar Documents

Publication Publication Date Title
US6127384A (en) Compounds, compositions and methods for treatment of hepatitis C
SU1349700A3 (ru) Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами
CZ178993A3 (en) Hydrochloride of 5-(2-(4-(1,2-benzothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one monohydrate, process of its preparation and pharmaceutical preparations in which such monohydrate is comprised
SI9300287A (en) Process for preparing aryl piperazinyl-heterocyclic compounds
EP0066459B1 (en) Crystalline benzothiazine dioxide salts
IE912061A1 (en) Aminobenzodiazepines
CS195280B2 (en) Method of producing substituted chalcones
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
GB2190677A (en) 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
US4088768A (en) N-heterocyclic ureas as immune regulants
US3950537A (en) Gastrointestinally active thioureas
JPS61186378A (ja) オキソ化合物の窒素誘導体，その製法及びそれを含む医薬製剤
US4076824A (en) Anthelmintic oxadiazolinone derivatives
US3740434A (en) Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents
JPH01319487A (ja) イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
US3772325A (en) Novel hexahydro cyclohept(b)indoles
US4423053A (en) Derivatives of 2-amino-5-(o-sulphamidophenyl)-1,3,4-thiadiazol as antiviral agents and a process for the preparation thereof
JP2911956B2 (ja) ５，１１―ジヒドロ―６Ｈ―ピリド［２，３―ｂ］［１，４］ベンゾジアゼピン―６―オン及び―チオン並びに該化合物のＡＩＤＳの予防又は治療における使用法
US4171364A (en) N-heterocyclic ureas as immune regulants
IE44948B1 (en) 7h-thiazolo(and 1,3,4-thiadiazolo-)(3,2-alpha)pyrimidin-7-one-5-carboxylic acids,derivatives and medicaments thereof
CA1287052C (en) Pyrimido[5,4-b][1,4]oxazine derivatives, pharmaceutical compositions containing them and process for preparing same
JP2927932B2 (ja) ピリジニルオキサゾール―２―オン類による糖蛋白エンベロープを着たウィルスの感染力の防止
JPS61130291A (ja) アルキリデンジオキシ化合物、その製法およびそれを含む医薬製剤
IL44470A (en) History of 8 - Phenyl - 5 - Oxo - 2,3, - Dihydro - Imidazo] a [- s-1,2- Preparation and pharmaceutical preparations containing them
RU2264397C2 (ru) Производные 1-азиридино-1-гидроксииминометила, способ их получения и лекарственные препараты, содержащие эти соединения